Neha Raghani

Dr. Neha Raghani

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 September 2023 in Biomedicines
Verified
Journal Article
Open access
PDF file
Bhagavathi Sundaram SivamaruthiBhagavathi Sundaram Sivamaruthi
Bhagavathi Sundaram Sivamaruthi
NRNeha Raghani
Neha Raghani
MCMehul R Chorawala
Mehul R Chorawala
SBSankha Bhattacharya
Sankha Bhattacharya
Bhupendra G PrajapatiBhupendra G Prajapati
Bhupendra G Prajapati
Chaiyavat ChaiyasutChaiyavat Chaiyasut
Chaiyavat Chaiyasut
The nuclear factor kappa B (NF-κB) pathway has emerged as a pivotal player in the pathogenesis of various diseases, including neurodegenerative illnesses like Alzheimer’s disease (AD). The involvement of the NF-κB pathway in immune system responses, inflammation, oxidative stress, and neuronal survival highlights its significance in AD progression. We discuss the advantages of NF-κB pathway inhibition, including the potential to mitigate neuroinflammation, modulate amyloid beta (Aβ) production, and promote neuronal survival. However, we also acknowledge the limitations and challenges associated with this approach. Balancing the fine line between dampening inflammation and preserving physiological immune responses is critical to avoid unintended consequences. This review combines current knowledge on the NF-κB pathway’s intricate involvement in AD pathogenesis, emphasizing its potential as a therapeutic target. By evaluating both advantages and limitations, we provide a holistic view of the feasibility and challenges of NF-κB pathway modulation in AD treatment. As the quest for effective AD therapies continues, an in-depth understanding of the NF-κB pathway’s multifaceted roles will guide the development of targeted interventions with the potential to improve AD management.

18 March 2025 in Medical Oncology
Verified
Journal Article
Closed access
PDF file
DSDisha D. Shah
Disha D. Shah
MCMehul R Chorawala
Mehul R Chorawala
NRNeha Raghani
Neha Raghani
RPRajanikant Patel
Rajanikant Patel
MFMohammad Fareed
Mohammad Fareed
Bhupendra G PrajapatiBhupendra G Prajapati
Bhupendra G Prajapati

9 January 2024 in Medical Oncology
Verified
Journal Article
Closed access
PDF file
NRNeha Raghani
Neha Raghani
MCMehul R Chorawala
Mehul R Chorawala
MMMayuresh Mahadik
Mayuresh Mahadik
RPRakesh B. Patel
Rakesh B. Patel
Bhupendra G PrajapatiBhupendra G Prajapati
Bhupendra G Prajapati
PPPriyajeet S. Parekh
Priyajeet S. Parekh

30 September 2024 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
DIDipa K Israni
Dipa K Israni
NRNeha Raghani
Neha Raghani
JSJhanvi Soni
Jhanvi Soni
MSMansi Shah
Mansi Shah
Bhupendra G PrajapatiBhupendra G Prajapati
Bhupendra G Prajapati
CCChuda Chittasupho
Chuda Chittasupho
Cannabis sativa emerges as a noteworthy candidate for its medicinal potential, particularly in wound healing. This review article explores the efficacy of cannabis oil in reducing reactive oxygen species (ROS) during the healing of acute and chronic wounds, comparing it to the standard treatments. ROS, produced from various internal and external sources, play a crucial role in wound development by causing cell and tissue damage. Understanding the role of ROS on skin wounds is essential, as they act both as signaling molecules and contributors to oxidative damage. Cannabis oil, recognized for its antioxidant properties, may help mitigate oxidative damage by scavenging ROS and upregulating antioxidative mechanisms, potentially enhancing wound healing. This review emphasizes ongoing research and the future potential of cannabis oil in dermatological treatments, highlighted through clinical studies and patent updates. Despite its promising benefits, optimizing cannabis oil formulations for therapeutic applications remains a challenge, underscoring the need for further research to realize its medicinal capabilities in wounds.

3 June 2024 in Probiotics and Antimicrobial Proteins
Verified
Journal Article
Closed access
PDF file
NRNeha Raghani
Neha Raghani
Humzah Ilyas PostwalaHumzah Ilyas Postwala
Humzah Ilyas Postwala
YSYesha Bhavesh Shah
Yesha Bhavesh Shah
MCMehul R Chorawala
Mehul R Chorawala
PPPriyajeet S. Parekh
Priyajeet S. Parekh

4 May 2025 in Medical Oncology
Verified
Journal Article
Closed access
PDF file
NRNeha Raghani
Neha Raghani
MCMehul R Chorawala
Mehul R Chorawala
KPKavya Parekh
Kavya Parekh
ASAnvesha Sharma
Anvesha Sharma
OAOmar Awad Alsaidan
Omar Awad Alsaidan
Bhupendra G PrajapatiBhupendra G Prajapati
Bhupendra G Prajapati